Increasing adoption of therapeutic antibodies along with elevated rate of product approval in developing countries is propelling the growth of the global antibodies market. The market had surpassed US$ 104 Bn in 2016. Additionally, approval of monoclonal antibody products, combined with drug conjugates, antibody fragments, and therapeutic antibodies in key markets of Europe, Japan and the U.S. have boosted the growth of the market as well as inexpensive biosimilar antibody therapeutics available in the market is another driving factor for the market
According to a recent study conducted by RRI, the global market for hepatitis C treatment is expected to expand at a CAGR of over 13% during the forecast period (2016-2024). By the end of 2016, market is anticipated to stand at US$ 26.6 and is estimated to surpass US$ 71 Billion by 2024.
According to a recent study conducted by RRI, the global market for neuropathic pain is expected to reflect a CAGR of over 5% during the forecast period (2016–2024). In 2015, the market was valued at over US$ 5 Billion and is estimated to stand at US$ 8.3 Billion by 2024 end.
Dysphagia is “difficulty in swallowing”, whereas eating difficulties refer to problems associated with transfer of liquid/food to the mouth. These problems coexists in many patients. Dysphagia is a common issue after stroke. In many cases, dysphagia gets resolved rapidly. However, in some cases, the swallow varies in function. Dysphagia has become a prevalent difficulty among geriatric population.
Rising optometric clinical practice is expected to provide an impetus to the growth of the global uveitis treatment market. Growing prevalence of uveitis with the projects on development of biological drugs is expected to fuel the demand for uveitis treatment. In addition, surging prevalence of TB associated intermediate uveitis is further expected to boost the growth of the global uveitis treatment market in the future.
According to the Research Report Insights (RRI), titled ‘Global Sleep AidsMarket’: Industry Analysis 2012-2016 and Opportunity Assessment 2017-2025. The global sleep aids market is expected to expand at a CAGR of 4.8% during the forecast period 2017-2025.
Government’s initiatives in various countries is fuelling growth of the environmental testing globally. In addition, with the growing demand for development of waste infrastructure the liquid chromatography-mass spectroscopy is expected to witness an upsurge in adoption in the coming years.
According to the latest market report published by Research Report Insights (RRI) titled ‘Single-lead ECG Monitors Market’, the marketis poisedto expand at a CAGR of 9.9% over the forecast period (2017–2025).
According to the latest market report published by Research Report Insights, titled ‘Global Hospital Acquired Infections ControlMarket’: Industry Analysis 2012-2016and Forecast2017-2025. The global hospital acquired infections control market is expected to expand at a CAGR of 4.8% during the forecast period 2017-2025.
Surge in projects regarding toxicity studies and drug discovery has led to an upsurge in demand for techniques related to high content screening in the pharmaceutical industry. Moreover, growing support from the government is expected to impact the global market growth of content screening positively.
Copyrights © 2018 Research Report Insights. All rights reserved.